News
12 Health Care Stocks Moving In Friday's After-Market Session
26 Apr 24
Movers
HC Wainwright & Co. Reiterates Buy on ASLAN Pharma, Maintains $9 Price Target
23 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Aslan Pharmaceuticals Reports Interim Results From Phase 2 Study Of Eblasakimab In Dupilumab-Experienced Atopic Dermatitis Patients
22 Apr 24
Biotech, News, General
HC Wainwright & Co. Reiterates Buy on ASLAN Pharma, Maintains $9 Price Target
15 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Piper Sandler Reiterates Overweight on ASLAN Pharma, Lowers Price Target to $10
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Piper Sandler Maintains Overweight on ASLAN Pharma, Lowers Price Target to $10
13 Mar 24
News, Price Target, Analyst Ratings
Piper Sandler Maintains Overweight on ASLAN Pharma, Maintains $15 Price Target
11 Mar 24
News, Price Target, Analyst Ratings
12 Health Care Stocks Moving In Monday's Intraday Session
11 Mar 24
Movers
ASLAN Pharmaceuticals Begins To Enroll Patients In US Under An Updated Protocol In The Ongoing TREK-DX Trial
11 Mar 24
News
ASLAN Pharmaceuticals Announced New Translational Data From A Head-to-head Study Of Eblasakimab Versus Dupilumab In A Human Tissue Model Of Chronic Obstructive Pulmonary Disease
6 Mar 24
Biotech, News, Health Care, General
12 Health Care Stocks Moving In Monday's Intraday Session
5 Feb 24
Movers
Press releases
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
22 Apr 24
Health Care, Press Releases, General
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
19 Apr 24
Markets, Press Releases
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
12 Apr 24
Earnings, Press Releases
Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
27 Mar 24
News, Press Releases
ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering
12 Mar 24
Press Releases
ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors
6 Mar 24
Health Care, Press Releases, General